Filing Details
- Accession Number:
- 0001209191-14-034671
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-16 16:48:15
- Reporting Period:
- 2014-05-14
- Filing Date:
- 2014-05-16
- Accepted Time:
- 2014-05-16 16:48:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1196903 | Patrick L Gage | 480 Arsenal St, Suite 110 Watertown MA 02472 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-14 | 5,000 | $9.25 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported represents the weighted average purchase price of shares purchased in multiple transactions at prices ranging from $9.24 to $9.25 per share. The reporting person undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.